Access to Medicine: Lenalidomide
Cancer Alliance submitted a case for the investigation of excessive pricing for lenalidomide to the South African Competition Commission in January 2023. The CompCom confirmed their intention to investigate this case in February 2023.
Related
Represented by SECTION27, takes on multinational company Cancer Alliance tackles price gouging 14 November 2024, Johannesburg - The Cancer Alliance, represented by SECTION27, has been admitted by the Competition Tribunal as an intervening party in the excessive...
– INTERVIEW SALOME MEYER https://youtu.be/IygOCleU1Z4 SABC TV interviewed Salome Meyer from the Cancer Alliance on the problems around the cost of cancer medications, particularly Herceptin (trastuzumab), an important drug used for certain types of breast...
https://www.youtube.com/watch?v=y6KaJ6q2-p4 It’s a story often repeated in South Africa’s neglected public healthcare system: old equipment, untrained staff, and a general lack of resources. In Gauteng, it’s a story that’s grown to reveal an unprecedented level of...
